 | Up a level |
Suker, Samir; Mihov, Yoan; Wolf, Andreas; Mueller, Stefanie V; Hasler, Gregor (2023). Behavioral Response to Catecholamine Depletion in Individuals With Schizophrenia and Healthy Volunteers. Schizophrenia Bulletin Open, 4(1), sgad023. Oxford University Press 10.1093/schizbullopen/sgad023
Hasler, Gregor; Suker, Samir; Schoretsanitis, Georgios; Mihov, Yoan (2020). Sustained Improvement of Negative Self-Schema After a Single Ketamine Infusion: An Open-Label Study. Frontiers in neuroscience, 14(687), p. 687. Frontiers Research Foundation 10.3389/fnins.2020.00687
Müller Herde, Adrienne; Mihov, Yoan; Krämer, Stefanie D; Mu, Linjing; Adamantidis, Antoine; Ametamey, Simon M; Hasler, Gregor (2019). Chronic Nicotine Exposure Alters Metabotropic Glutamate Receptor 5: Longitudinal PET Study and Behavioural Assessment in Rats. Neurotoxicity research, 36(4), pp. 806-816. Springer 10.1007/s12640-019-00055-5
Müller, Stefanie Verena; Mihov, Yoan; Federspiel, Andrea; Wiest, Roland; Hasler, Gregor (2017). Neural response to catecholamine depletion in remitted bulimia nervosa: Relation to depression and relapse. European neuropsychopharmacology, 27(7), pp. 633-646. Elsevier 10.1016/j.euroneuro.2017.04.002
Mihov, Yoan (2016). Positron emission tomography studies on cannabinoid receptor type 1 in schizophrenia. Biological psychiatry, 79(12), e97-e99. Elsevier 10.1016/j.biopsych.2016.04.015
Mihov, Yoan; Hasler, Gregor (2016). Negative allosteric modulators of metabotropic glutamate receptors subtype 5 in addiction: a therapeutic window. International journal of neuropsychopharmacology, 19(7), pp. 1-11. Cambridge University Press 10.1093/ijnp/pyw002
Hasler, Gregor; Schoretsanitis, Georgios; Suker, Samir; Mihov, Yoan (2019). Ketamine Improves Negative Attitudes Toward Self in Treatment-Resistant Depression. Neuropsychopharmacology, 44, p. 429. Springer Nature
Hasler, Gregor; Akkus, Funda; Treyere, Valerie; Ametamey, Simon; Mihov, Yoan; Herde, Adrienne; Kraemer, Stefanie; Buck, Fredi; Johayem, Anass (October 2016). mGluR5 binding as a specific biomarker for nicotine dependence and relapse in humans. European neuropsychopharmacology, 26(2), S126. Elsevier 10.1016/S0924-977X(16)30903-8
